Catalyst
Slingshot members are tracking this event:
European Commission Grants Marketing Authorization for Gilead’s Once-Daily Truvada For Reducing the Risk of Sexually Acquired HIV-1
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| GILD |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 22, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Sexually Acquired Hiv, Marketing Authorization, Truvada, Pre-exposure Prophylaxis
